Suppr超能文献

胚系 CDH1 突变的多效性癌症表现:风险与管理。

Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management.

机构信息

Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

出版信息

J Surg Oncol. 2022 Jun;125(8):1326-1331. doi: 10.1002/jso.26847. Epub 2022 Mar 12.

Abstract

Germline CDH1 defects are related with the development of multiple cancers due its pleiotropic nature. These several conditions are associated with various risks of penetrance and with different clinical management strategies. In this clinical review, we described the penetrance risks of gastric, breast, prostate, and colorectal cancers, in CDH1 carriers, within as well as outside the familial setting, and the best approaches to manage each risk, using either prophylactic surgery or surveillance.

摘要

胚系 CDH1 缺陷因其多效性而与多种癌症的发生有关。这些疾病与不同的外显率风险和不同的临床管理策略相关。在本次临床综述中,我们描述了 CDH1 携带者在家族性和非家族性环境中发生胃癌、乳腺癌、前列腺癌和结直肠癌的外显率风险,以及使用预防性手术或监测来管理每种风险的最佳方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2fb/9313879/cfd9c31bcf31/JSO-125-1326-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验